Day September 24, 2019

WI Harper-backed EdiGene has completed an RMB 81.5 million Pre-B2 financing round and announced R&D collaboration of T-cell cancer therapy

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.